GMO US Value ETF
GMOV
6 hedge funds and large institutions have $9.04M invested in GMO US Value ETF in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, reducing their positions, and 2 closing their positions.
86% more capital invested
Capital invested by funds: $4.86M → $9.04M (+$4.19M)
2.5% less ownership
Funds ownership: 19.88% → 17.38% (-2.5%)
14% less funds holding
Funds holding: 7 → 6 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$2.64M |
| 2 |
LCWP
Legacy Capital Wealth Partners
Little Rock,
Arkansas
|
+$1.39M |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
+$634K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$181K |
| 5 |
CFG
Certior Financial Group
King Of Prussia,
Pennsylvania
|
+$168K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$732K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$15K |
GMOV Hedge Fund Activity: Q1 2025 in Review
6 of the 7,464 institutional investors tracked by Wall St. Rank reported a position in GMO US Value ETF (GMOV) for Q1 2025, worth a combined $9.04M — up 86% from $4.86M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of GMOV and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 4 added.
The largest buyer was HighTower Advisors, opening a new position worth an estimated $2.64M. The largest seller was Citadel Advisors, exiting entirely with an estimated $732K sold.
- 6 institutional investors held GMO US Value ETF (GMOV) as of Q1 2025, down from 7 in Q4 2024.
- Funds reported $9.04M of GMO US Value ETF stock for Q1 2025, up 86% quarter-over-quarter.
- 1 fund opened new GMO US Value ETF positions in Q1 2025 and 2 closed out, a net change of -1 holder.
- The largest GMO US Value ETF buyer in Q1 2025 was HighTower Advisors, an estimated $2.64M added.
- The largest GMO US Value ETF seller in Q1 2025 was Citadel Advisors, an estimated $732K sold.
Based on aggregated 13F filings for Q1 2025.